TrialScope Blog

The TrialScope team discusses clinical trial disclosure and compliance topics

  • Podcast: Clinical Trial Disclosures on the World Map

    Podcast: Clinical Trial Disclosures on the World Map

    Chief Strategy Officer Thomas Wicks discusses clinical trial transparency on the Nota Bene podcast hosted by the Sheppard Mullin law firm.

    Read Article
  • Transparency & Other Takeaways from COVID-19 Clinical Trials

    Transparency & Other Takeaways from COVID-19 Clinical Trials

    The COVID-19 pandemic underscores the importance of clinical trial recruitment, data sharing and transparency.

    Read Article
  • Want to be More Patient Centric? Start with PLS

    Want to be More Patient Centric? Start with PLS

    Read Article
  • An Often-overlooked Way to Participate in Clinical Research

    An Often-overlooked Way to Participate in Clinical Research

    Many blood donors don't realize that their blood also can be used in clinical research. Now, as COVID-19 threatens to create blood shortages, donating blood is more important than ever.

    Read Article
  • What’s Yoga Got to Do with Clinical Trial Access?

    What’s Yoga Got to Do with Clinical Trial Access?

    How setting an intention for yoga can serve as a mantra for anyone working in the healthcare industry.

    Read Article
  • Podcast: Overcoming Clinical Trial Obstacles

    Podcast: Overcoming Clinical Trial Obstacles

    Mike Wenger, Vice President of Patient Engagement, talks about ways to improve the clinical trials process by focusing more on the patients who are being recruited, tracked and retained.

    Read Article
  • 5 Reasons Why Transparency is Good Business

    5 Reasons Why Transparency is Good Business

    Beyond regulatory compliance, transparency is simply good business. For starters, it puts companies in a favorable light with the public and investors.

    Read Article
  • 5 Key KPIs Every Disclosure Team Should Monitor – and Why

    5 Key KPIs Every Disclosure Team Should Monitor – and Why

    Clinical trial disclosure teams must be accountable. Here are five key performance indicators (KPIs) to monitor on a regular basis.

    Read Article
  • Good Pharma Scorecard: See What the Top 5 Sponsors Have in Common

    Good Pharma Scorecard: See What the Top 5 Sponsors Have in Common

    The Good Pharma Scorecard, as its acronym suggests, is the industry GPS for clinical trial transparency. See what this year's top-ranked sponsors all have in common.

    Read Article
  • For Sponsors with Global Trials, Online Translation is a Must

    For Sponsors with Global Trials, Online Translation is a Must

    If you conduct global clinical trials and your website is in English only, you are missing out on a huge opportunity to promote your studies. That's why local language translations are crucial.

    Read Article
  • Learn How User Research Boosts Clinical Trial Website ROI

    Learn How User Research Boosts Clinical Trial Website ROI

    Conversion rate optimization and A/B testing are an important part of the online marketing strategy for a clinical trial website.

    Read Article
  • Clinical Research: Aiding The Advancement Of Science And The U.S. Economy

    Clinical Research: Aiding The Advancement Of Science And The U.S. Economy

    As technologies and treatments advance, the clinical trial industry continues to expand and the number of trials initiated each year continues to grow. This is good news for local economies.

    Read Article
  • Using Technology For Successful Clinical Trial Recruitment

    Using Technology For Successful Clinical Trial Recruitment

    Three primary barriers stand in the way of clinical trial participation: awareness, access and eligibility. Study recruitment is one area where study sponsors can use technology to their advantage.

    Read Article
  • Finding Trial Summaries Online a Plus for Patients

    Finding Trial Summaries Online a Plus for Patients

    The Trial Results Summaries portal is a centralized repository, a neutral ground where multiple sponsors can post clinical trial results online. TrialSummaries.com is a one-stop shop for PLS.

    Read Article
  • Behind the Scenes: In-house vs. Outsourced Clinical Trial Websites

    Behind the Scenes: In-house vs. Outsourced Clinical Trial Websites

    A digital health adviser discusses the pros and cons of a DIY clinical trials website vs. outsourcing development and design.

    Read Article
  • Vetting Your Vendor: A Reputation for Success

    Vetting Your Vendor: A Reputation for Success

    Not all vendors are created equally, especially when it comes to clinical trial disclosure. Do your research. How long has the vendor been in business? What's its client roster? What's its reputation?

    Read Article
  • Diversity in Clinical Trials Improving, but We’re Not There Yet

    Diversity in Clinical Trials Improving, but We’re Not There Yet

    Dr. Jean Bonnet, an advocate for diversity in clinical trials, says both sponsors and patients are to blame for the lack of diversity. He says grassroots communication is key to effecting change.

    Read Article
  • With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent

    With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent

    With the government shutdown and public outcry over drug prices, biotech companies face new challenges when courting investors. That means transparency is more important than ever.

    Read Article
  • Health Literacy the Key to Opening the Door to Clinical Trials

    Health Literacy the Key to Opening the Door to Clinical Trials

    When it comes to health literacy, it’s not enough to just know that clinical trials are out there. As patients, we need information presented in plain language that is easily understood.

    Read Article
  • A Dozen Disclosure & Transparency Predictions for 2019

    A Dozen Disclosure & Transparency Predictions for 2019

    Clinical trial disclosure and transparency experts Francine Lane and Thomas Wicks make their 2019 predictions on patient-centricity, industry watchdogs, regulatory agencies, medical devices, and data.

    Read Article
  • loading
    Loading More...